282 related articles for article (PubMed ID: 27857177)
41. MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.
Bertoli G; Cava C; Diceglie C; Martelli C; Rizzo G; Piccotti F; Ottobrini L; Castiglioni I
Breast Cancer Res Treat; 2017 Feb; 161(3):605-616. PubMed ID: 28000015
[TBL] [Abstract][Full Text] [Related]
42. Decreased miR-320 expression is associated with breast cancer progression, cell migration, and invasiveness via targeting Aquaporin 1.
Luo L; Yang R; Zhao S; Chen Y; Hong S; Wang K; Wang T; Cheng J; Zhang T; Chen D
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):473-480. PubMed ID: 29538612
[TBL] [Abstract][Full Text] [Related]
43. MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.
Gao Y; Zeng F; Wu JY; Li HY; Fan JJ; Mai L; Zhang J; Ma DM; Li Y; Song FZ
Tumour Biol; 2015 Apr; 36(4):2875-83. PubMed ID: 25492484
[TBL] [Abstract][Full Text] [Related]
44. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
46. Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer.
Chen Y; Luo D; Tian W; Li Z; Zhang X
Oncol Rep; 2017 Jun; 37(6):3581-3589. PubMed ID: 28498478
[TBL] [Abstract][Full Text] [Related]
47. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
[TBL] [Abstract][Full Text] [Related]
50. miR-145 overexpression triggers alteration of the whole transcriptome and inhibits breast cancer development.
Ye P; Shi Y; An N; Zhou Q; Guo J; Long X
Biomed Pharmacother; 2018 Apr; 100():72-82. PubMed ID: 29425746
[TBL] [Abstract][Full Text] [Related]
51. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway.
Wang B; Mao JH; Wang BY; Wang LX; Wen HY; Xu LJ; Fu JX; Yang H
Cancer Lett; 2020 Oct; 489():87-99. PubMed ID: 32531321
[TBL] [Abstract][Full Text] [Related]
52. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.
Zhang C; Xu B; Lu S; Zhao Y; Liu P
Mol Cancer; 2017 May; 16(1):90. PubMed ID: 28490334
[TBL] [Abstract][Full Text] [Related]
53. MiR-19b suppresses PTPRG to promote breast tumorigenesis.
Liu M; Yang R; Urrehman U; Ye C; Yan X; Cui S; Hong Y; Gu Y; Liu Y; Zhao C; Yan L; Zhang CY; Liang H; Chen X
Oncotarget; 2016 Sep; 7(39):64100-64108. PubMed ID: 27602768
[TBL] [Abstract][Full Text] [Related]
54. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
55. CircMMD_007 promotes oncogenic effects in the progression of lung adenocarcinoma through microRNA-197-3p/protein tyrosine phosphatase non-receptor type 9 axis.
Zhu L; Guo T; Chen W; Lin Z; Ye M; Pan X
Bioengineered; 2022 Mar; 13(3):4991-5004. PubMed ID: 35156900
[TBL] [Abstract][Full Text] [Related]
56. MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.
Zhao J; Jiang GQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8763-8771. PubMed ID: 30575917
[TBL] [Abstract][Full Text] [Related]
57. HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
Zhou Y; Yuan Y; Li L; Wang X; Quan Y; Liu C; Yu M; Hu X; Meng X; Zhou Z; Zhang CY; Chen X; Liu M; Wang C
PLoS One; 2021; 16(2):e0245832. PubMed ID: 33529238
[TBL] [Abstract][Full Text] [Related]
58. Suppressive role of miR-592 in breast cancer by repressing TGF-β2.
Hou W; Zhang H; Bai X; Liu X; Yu Y; Song L; Du Y
Oncol Rep; 2017 Dec; 38(6):3447-3454. PubMed ID: 29039599
[TBL] [Abstract][Full Text] [Related]
59. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
Lei L; Huang Y; Gong W
Oncol Rep; 2013 Dec; 30(6):2897-902. PubMed ID: 24084898
[TBL] [Abstract][Full Text] [Related]
60. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
Xia H; Long J; Zhang R; Yang X; Ma Z
Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
